Rubius Therapeutics started at overweight with $28 stock price target at J.P. Morgan

0
243



This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.





Source : MTV